A Phase 3 trial of onapristone extended release (ONA-XR)
Latest Information Update: 18 May 2021
At a glance
- Drugs Onapristone (Primary)
- Indications Breast cancer; Endometrial cancer; Ovarian cancer; Peritoneal cancer; Prostate cancer
- Focus Registrational; Therapeutic Use
- Sponsors Context Therapeutics
- 18 May 2021 New trial record